Teva Recalls Children's Qnasl Nasal Aerosol Due to Dosage Issues
Teva North America recalls Children's Qnasl 40 mcg nasal aerosol due to failed content uniformity. Check lot #150328 for details.
Use caution until it’s fixed
Failed Content Uniformity Specifications: out of specification test result for spray content uniformity.
Contact the company
What happened, in plain English
Teva North America is recalling Children's Qnasl 40 mcg Nasal Aerosol because the spray content does not meet uniformity specifications, meaning each spray may not deliver the correct dose. The recall affects approximately 193,320 canisters distributed nationwide. No remedy or return instructions are currently listed in the record. Read more at govinfonow.com/recall/42549-teva-recalls-children-s-qnasl-nasal-aerosol-due-to-dosage.
Source Summary by GovInfoNow · govinfonow.com/recall/42549-teva-recalls-children-s-qnasl-nasal-aerosol-due-to-dosage · Updated October 9, 2026 · FDA enforcement record: FDA #D-1453-2016
Cite this page
“Teva Recalls Children's Qnasl Nasal Aerosol Due to Dosage Issues.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42549-teva-recalls-children-s-qnasl-nasal-aerosol-due-to-dosage. Based on FDA recall #D-1453-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1453-2016%22&limit=1).
Why it’s dangerous
The product failed content uniformity specifications during testing. This means the amount of active ingredient (beclomethasone dipropionate) in each spray may vary from the labeled 40 mcg, potentially leading to under-dosing or over-dosing.
Who’s affected
Parents and caregivers who purchased Children's Qnasl nasal aerosol for children may have this product. The specific risk is limited to those with lot #150328, which expired in October 2017.
How to tell if you have this one
Check if you have Children's Qnasl 40 mcg Nasal Aerosol with NDC 59310-206-08. Look for Lot #150328 on the packaging. The product contains 60 metered sprays per canister and was manufactured by 3M Drug Delivery Systems.
- Brand
Teva- Category
Drug
What to do — step by step
Check Your Product Details
Verify if your nasal aerosol matches NDC 59310-206-08 and Lot #150328.
Monitor for Updates
Since no remedy is currently stated, watch for official updates from Teva North America regarding returns or refunds.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1453-2016 (July 15, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1453-2016 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.